Theodoros Dimitroulas
Theodoros Dimitroulas
ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study [0.03%]
一项针对住院患者的随机开放标签对照研究：促肾上腺皮质激素与倍他米松治疗急性痛风的比较研究
Dimitrios Daoussis,Panagiotis Kordas;Collaborators
Dimitrios Daoussis
Background: Hospitalized patients usually have significant comorbidities and receive multiple medications which leads to a high frequency of contraindications to standard treatment options for acute gout (NSAIDs, colchici...
Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment [0.03%]
非感染性原发性血管炎患者血管损伤的广泛表型研究：无创性血管生物标志物在患病率、发病机制及治疗反应中的应用
Ourania Agryropoulou,Athanase Protogerou,Antonis Argyris et al.
Ourania Agryropoulou et al.
Non-Infectious Primary systemic vasculitides (NIPSV) encompass a subset of autoimmune diseases, characterized mainly by intramural inflammation of the vascular wall. The increased mortality that some exhibit is partially attributed to vascu...
Nikolaos Marketos,Ilias Bournazos,Dimitrios Ioakimidis
Nikolaos Marketos
Rheumatoid arthritis is a common autoimmune disease leading often to joint destruction and reduced quality of life. We report a case of a young woman with rheumatoid arthritis with fever and rapid, destructive joint involvement verified wit...
Secondary hemophagocytic lymphohistiocytosis in a patient with rheumatoid arthritis and vasculitis: a case report and review of the literature [0.03%]
风湿和血管炎患者继发性噬血细胞综合征1例并文献复习
Panagiotis Panagopoulos,Gkikas Katsifis
Panagiotis Panagopoulos
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder characterized by excessive systemic inflammation, caused by uncontrolled activation of lymphocytes and macrophages, which secrete increased amounts of cytokines. HLH ma...
Transition of pediatric patients with an Auto-inflammatory Disease: an alternative version of the Daedaulus and Icarus myth [0.03%]
儿科.auto炎症性疾病患者的过渡：达达勒斯和伊卡洛斯神话的另一种版本
Polyxeni Pratsidou-Gertsi
Polyxeni Pratsidou-Gertsi
Progress in the pediatric Auto-inflammatory Diseases (AIDs) has led to improved long-term outcome and the increased pool of pediatric patients who require lifelong monitoring. Implementation of a successful stepwise transition in patients w...
Anna Christoforidou,Nikolaos Galanopoulos
Anna Christoforidou
Background: Human immunodeficiency virus (HIV) infection has been associated with various autoimmune disorders. Aim: To review the spec...
Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies [0.03%]
系统性硬化症的间质性肺病：对发病机制和治疗方法的新认识
Sakir Ahmed,Sarit Sekhar Pattanaik,Mohit Kumar Rai et al.
Sakir Ahmed et al.
Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc). However, mortality is improving as pathogenesis is being better understood and new therapies emerge. The roles of the inflammasome and NETosis in f...
Sevastiani Ziaragkali,Aggeliki Kotsalidou,Nikolaos Trakos
Sevastiani Ziaragkali
Dry eye disease (DED) is one of the most frequent ophthalmological conditions, with a major impact on patients' quality of life. Tear film instability and tear hyperosmolarity are considered to play a crucial role in the vicious cycle of dr...
Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece [0.03%]
希腊系统性硬化症患者的多参数自身抗体谱分析
Christos Liaskos,Emmanouela Marou,Theodora Simopoulou et al.
Christos Liaskos et al.
Background: Systemic sclerosis (SSc) is an autoimmune rheumatic disease characterized by a wide range of disease-specific and disease-related autoantibodies (autoAbs). Profile assays have been developed and are currently ...